Cytosorbents

CTSONasdaq United States Health Care Medical/Dental Instruments

Market cap

$14.495 M

$4.60 +0.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Cytosorbents (CTSO) has a market capitalization of $14.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$8.20M

Loss-making

Shares outstanding

62,842,748

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →

#95Retractable TechnologiesRVP$16.9M
#96AccurayARAY$14.6M
#97CytosorbentsCTSO$14.5M
#98PAVmedPAVM$12.9M
#99Modular MedicalMODD$12.3M

What if Cytosorbents were worth as much as…

Open the what-if tool →

Gold $28.2T

$8,960,955

Per share 1,947,991× higher

Bitcoin $1.53T

$484,861.65

Per share 105,402× higher

Apple $5.02T

$1,591,756

Per share 346,026× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Cytosorbents are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.